Showing results (401-410 of 498) with videos related to
Sort By:
Pageof 50
Clinical Lymphoma, Myeloma & Leukemia|March 7, 2024
Healthcare Resource Utilization and Cost-of-Illness in Systemic Light Chain (AL) Amyloidosis in Europe: Results From the Real-World, Retrospective EMN23 StudyArnaud Jaccard, Frank Bridoux, Wilfried Roeloffzen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2016
International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal ImpairmentMeletios A Dimopoulos, Pieter Sonneveld, Nelson Leung, et al.Ejhaem|March 20, 2025
Bortezomib, Rituximab and Dexamethasone Regimen (BDR) in Waldenström Macroglobulinaemia: A Retrospective Real-World AnalysisThomas Hueso, Grégory Lazarian, Paul Chauvet, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|October 9, 2023
Spatial Transcriptomics Reveal Pitfalls and Opportunities for the Detection of Rare High-Plasticity Breast Cancer SubtypesAngèle Coutant, Vincent Cockenpot, Lauriane Muller, et al.Giornale Italiano Di Cardiologia (2006)|February 3, 2026
[Light chain amyloidosis: multidisciplinary management and innovative therapeutic strategies. SIC/ANMCO Consensus document of the Italian Cardiac Amyloidosis Network (RIAC)]Alberto Aimo, Giuseppe Vergaro, Vincenzo Castiglione, et al.British Journal of Haematology|November 3, 2021
Accurate classification of plasma cell dyscrasias is achieved by combining artificial intelligence and flow cytometryValentin Clichet, Véronique Harrivel, Caroline Delette, et al.Blood Advances|May 7, 2021
Obinutuzumab and idelalisib in symptomatic patients with relapsed/refractory Waldenström macroglobulinemiaCécile Tomowiak, Stéphanie Poulain, Charles Herbaux, et al.Journal of Neural Engineering|December 9, 2015
Long-term decoding of movement force and direction with a wireless myoelectric implantPierre Morel, Enrico Ferrea, Bahareh Taghizadeh-Sarshouri, et al.Circulation|September 16, 2009
Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main typesClaudio Rapezzi, Giampaolo Merlini, Candida C Quarta, et al.Blood Cancer Journal|February 17, 2021
Minimal residual disease negativity by next-generation flow cytometry is associated with improved organ response in AL amyloidosisGiovanni Palladini, Bruno Paiva, Ashutosh Wechalekar, et al.Pageof 50